Zobrazeno 1 - 10
of 84
pro vyhledávání: '"I. Genvresse"'
Autor:
M Lawang, Oliver Rosen, Marion Nagy, Bernd Dörken, I Genvresse, Renate Arnold, G Geserick, Gero Massenkeil
Publikováno v:
Bone Marrow Transplantation. 31:339-345
23 patients with ALL (n=9) and AML (n=14) underwent nonmyeloablative stem cell transplantation (NST) from an HLA-identical donor after conditioning with fludarabine (180 mg/m(2)), busulfan (8 mg/kg) and anti-T-lymphocyte globulin (40 mg/kg). After NS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73719eecf9d82af63735d4a2eb1994e0
https://doi.org/10.1038/sj.bmt.1703859
https://doi.org/10.1038/sj.bmt.1703859
Publikováno v:
Bone Marrow Transplantation. 30:899-903
Basiliximab, a chimeric interleukin-2 receptor (IL-2-R) antagonist, was evaluated in 17 patients with steroid-refractory acute graft-versus-host disease (GVHD) after allogeneic stem cell transplantation (SCT). Patients were transplanted from a relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7eab55767c23aaebb9e7a297d2b173d
https://doi.org/10.1038/sj.bmt.1703737
https://doi.org/10.1038/sj.bmt.1703737
Autor:
Jan Eucker, Ernst Späth-Schwalbe, Orhan Sezer, Catalina Lange, Kurt Possinger, M. Schweigert, I. Genvresse, Larissa Krüger, Volker Budach
Publikováno v:
Anti-Cancer Drugs. 13:395-403
Due to concerns about toxicity, many elderly patients with aggressive non-Hodgkin's lymphoma (NHL) are not considered candidates for standard chemotherapy with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP). The cytoprotective agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a7c88ba8231742948d2700b7ef50ee
https://doi.org/10.1097/00001813-200204000-00008
https://doi.org/10.1097/00001813-200204000-00008
Publikováno v:
European Journal of Haematology. 68:84-90
The association of antiphospholipid antibodies (APA) has been reported in several cases of patients with non-Hodgkin's lymphoma (NHL) with or without thromboembolic complications. The purpose of this study was to analyse systematically the prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6415f33958216b3466c254d62e1b9df9
https://doi.org/10.1034/j.1600-0609.2002.01526.x
https://doi.org/10.1034/j.1600-0609.2002.01526.x
Publikováno v:
Oncology Research and Treatment. 24:386-390
Treatment of Multiple Myeloma in the Elderly: Consensus of the Cooperative Group of Geriatric Oncology of the DGHO and DGG Multiple myeloma is an illness of old age. Often, in elderly people the diagnosis is delayed by the fact that bone pain, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c618c21b44cdf2f48df9add93b9a2c7d
https://doi.org/10.1159/000055113
https://doi.org/10.1159/000055113
Autor:
Ernst Späth-Schwalbe, I. Genvresse, Georgios Plataniotis, Ulrich Wedding, J.H. Hartlapp, S. Linden-Lammering, C. Sachsenmaier, Martin C. Müller, G. Lammering, F. Fiedler, B. Straub, Anke Morgner, I.T.M. Boll, M.A. Theofanopoulou, A. Trojan, Günter Emons, Kurt Miller, T. Stallmach, S. Kollias, Mathias Hänel, G. Ehninger, M. Nicklisch, A. Chrissafidou, M. Teich, J. Mezger, Mark Schrader, T. Krauss, M. Malek, C. Marosi, Stephan Schmitz, Maria Piribauer, Regina Herbst, K. Friedrichsen, Volker Viereck, A. Huschmand Nia, S. Neser, B.C. Pestalozzi, Barbara Fazeny-Dörner, E. Musch, Ruediger Hehlmann, H.T. Steinmetz, G. Kolb, R. Heicappell, Carsten Bokemeyer, A. Hänel
Publikováno v:
Oncology Research and Treatment. 24:317-322
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc69e5ecaed7bfc7f735c2409db734bf
https://doi.org/10.1159/000055101
https://doi.org/10.1159/000055101
Publikováno v:
European Journal of Haematology. 65:344-347
Autoimmune phenomena in lymphoid malignancies are often observed. However, clinical manifestations such as a secondary antiphospholipid syndrome in the presence of antiphospholipid antibodies are rarely reported. Furthermore, in the few cases of lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c46bd1cd641c3a3cb19119a9dc9907c3
https://doi.org/10.1034/j.1600-0609.2000.065005344.x
https://doi.org/10.1034/j.1600-0609.2000.065005344.x
Publikováno v:
Anti-Cancer Drugs. 11:325-329
Because of the low number of active cytotoxic drugs and their limited activity, the evaluation of new anti-cancer agents for their activity in soft tissue sarcomas is a continuing need. The objectives of this prospective phase II trial of gemcitabine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26a81a31d0213b26de38196e1c8ab942
https://doi.org/10.1097/00001813-200006000-00002
https://doi.org/10.1097/00001813-200006000-00002
Autor:
V Budach, H Stein, R Lehmann, I. Genvresse, H Gelderblom, Ernst Späth-Schwalbe, Kurt Possinger
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 124:451-455
History and clinical findings A 40-year-old man was admitted with acute onset of positional vertigo, nausea and vomiting. Neurological examination revealed a fatigable nystagmus to the upward ear in positional testing, to the right more than to the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9ffd891b7cdd9ffba751da8bc9ccecf
https://doi.org/10.1055/s-2007-1024333
https://doi.org/10.1055/s-2007-1024333
Autor:
I, Genvresse, C, Carbon
Publikováno v:
International Journal of Antimicrobial Agents. 3:1-16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c3d7d0324a091ba72b0c117ff52bd5
https://doi.org/10.1016/0924-8579(93)90002-m
https://doi.org/10.1016/0924-8579(93)90002-m